STRYKER CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that STRYKER CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.17B | Feb 11, 2026 |
| FY2025 | Sep 30, 2025 | $6.06B | Feb 11, 2026 |
| FY2025 | Jun 30, 2025 | $6.02B | Feb 11, 2026 |
| FY2025 | Mar 31, 2025 | $5.87B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $6.44B | Feb 11, 2026 |
| FY2025 | Sep 30, 2024 | $5.49B | Feb 11, 2026 |
| FY2025 | Jun 30, 2024 | $5.42B | Feb 11, 2026 |
| FY2025 | Mar 31, 2024 | $5.24B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $5.82B | Feb 12, 2025 |
| FY2024 | Sep 30, 2023 | $4.91B | Feb 12, 2025 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $3.47B | Feb 8, 2018 |
| FY2017 | Sep 30, 2017 | $3.01B | Feb 8, 2018 |
| FY2017 | Jun 30, 2017 | $3.01B | Feb 8, 2018 |
| FY2017 | Mar 31, 2017 | $2.96B | Feb 8, 2018 |
| FY2017 | Dec 31, 2016 | $3.16B | Feb 8, 2018 |
| FY2017 | Sep 30, 2016 | $2.83B | Feb 8, 2018 |
| FY2017 | Jun 30, 2016 | $2.84B | Feb 8, 2018 |
| FY2017 | Mar 31, 2016 | $2.50B | Feb 8, 2018 |
| FY2016 | Dec 31, 2015 | $2.72B | Feb 9, 2017 |
| FY2016 | Sep 30, 2015 | $2.42B | Feb 9, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.63B | Feb 11, 2026 |
| FY2025 | Sep 30, 2025 | $3.85B | Feb 11, 2026 |
| FY2025 | Jun 30, 2025 | $3.84B | Feb 11, 2026 |
| FY2025 | Mar 31, 2025 | $3.74B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $4.17B | Feb 11, 2026 |
| FY2025 | Sep 30, 2024 | $3.52B | Feb 11, 2026 |
| FY2025 | Jun 30, 2024 | $3.42B | Feb 11, 2026 |
| FY2025 | Mar 31, 2024 | $3.33B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $3.70B | Feb 12, 2025 |
| FY2024 | Sep 30, 2023 | $3.16B | Feb 12, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $849.00M | Feb 11, 2026 |
| FY2025 | Sep 30, 2025 | $859.00M | Feb 11, 2026 |
| FY2025 | Jun 30, 2025 | $884.00M | Feb 11, 2026 |
| FY2025 | Mar 31, 2025 | $654.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $546.00M | Feb 11, 2026 |
| FY2025 | Sep 30, 2024 | $834.00M | Feb 11, 2026 |
| FY2025 | Jun 30, 2024 | $825.00M | Feb 11, 2026 |
| FY2025 | Mar 31, 2024 | $788.00M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $1.14B | Feb 12, 2025 |
| FY2024 | Sep 30, 2023 | $692.00M | Feb 12, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.89B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $3.69B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $3.89B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $2.84B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $2.58B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $2.22B | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $2.71B | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $2.54B | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $2.30B | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $2.18B | Feb 7, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.62B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.47B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $1.39B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $1.45B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $1.24B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $984.00M | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $971.00M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $862.00M | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $787.00M | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $715.00M | Feb 7, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.65B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $7.69B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $7.11B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $6.39B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $6.43B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $5.36B | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $5.36B | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $5.10B | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $4.55B | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $4.14B | Feb 7, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.04B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $4.24B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $3.71B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $2.62B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $3.26B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $3.28B | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $2.19B | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $2.61B | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $1.56B | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $1.92B | Feb 7, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $761.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $755.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $575.00M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $588.00M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $525.00M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $487.00M | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $649.00M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $572.00M | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $598.00M | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $490.00M | Feb 7, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $47.84B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $42.97B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $39.91B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $36.88B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $34.63B | Feb 10, 2023 |
| FY2022 | Dec 31, 2020 | $34.33B | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $30.17B | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $27.23B | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $22.20B | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $20.44B | Feb 7, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.42B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $22.34B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $21.32B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $20.27B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $19.75B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $21.25B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $17.36B | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | $15.50B | Feb 6, 2020 |
| FY2018 | Dec 31, 2017 | $12.22B | Feb 7, 2019 |
| FY2017 | Dec 31, 2016 | $10.89B | Feb 8, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $11.73B | Feb 7, 2019 |
| FY2018 | Dec 31, 2017 | $9.97B | Feb 7, 2019 |
| FY2017 | Dec 31, 2016 | $9.55B | Feb 8, 2018 |
| FY2016 | Dec 31, 2015 | $8.51B | Feb 9, 2017 |
| FY2016 | Dec 31, 2014 | $8.60B | Feb 9, 2017 |
| FY2016 | Dec 31, 2013 | $9.05B | Feb 9, 2017 |
| FY2015 | Dec 31, 2012 | $8.60B | Feb 11, 2016 |
| FY2014 | Dec 31, 2011 | $7.68B | Feb 12, 2015 |
| FY2013 | Dec 31, 2010 | $7.17B | Feb 13, 2014 |
| FY2012 | Dec 31, 2009 | $6.60B | Feb 27, 2013 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.29B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $15.86B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $15.24B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $14.88B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $12.92B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $12.78B | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $9.07B | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $8.56B | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $7.17B | Feb 6, 2020 |
| FY2018 | Dec 31, 2016 | $6.36B | Feb 7, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.47B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $18.53B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $16.77B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $14.77B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $13.48B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $12.46B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $11.75B | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | $10.77B | Feb 6, 2020 |
| FY2018 | Dec 31, 2017 | $8.99B | Feb 7, 2019 |
| FY2017 | Dec 31, 2016 | $8.84B | Feb 8, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.01B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $3.65B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $2.97B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $1.84B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $2.94B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $2.94B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $4.34B | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | $3.62B | Feb 6, 2020 |
| FY2019 | Dec 31, 2017 | $2.54B | Feb 6, 2020 |
| FY2019 | Dec 31, 2016 | $3.32B | Feb 6, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | $1.77B | Feb 13, 2012 |
| FY2011 | Dec 31, 2010 | $1.02B | Feb 13, 2012 |
| FY2010 | Dec 31, 2009 | $18.00M | Feb 18, 2011 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 11, 2026 |
| FY2025 | Sep 30, 2025 | 2 | Feb 11, 2026 |
| FY2025 | Jun 30, 2025 | 2 | Feb 11, 2026 |
| FY2025 | Mar 31, 2025 | 1 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 11, 2026 |
| FY2025 | Sep 30, 2024 | 2 | Feb 11, 2026 |
| FY2025 | Jun 30, 2024 | 2 | Feb 11, 2026 |
| FY2025 | Mar 31, 2024 | 2 | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | 3 | Feb 12, 2025 |
| FY2024 | Sep 30, 2023 | 1 | Feb 12, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 11, 2026 |
| FY2025 | Sep 30, 2025 | 2 | Feb 11, 2026 |
| FY2025 | Jun 30, 2025 | 2 | Feb 11, 2026 |
| FY2025 | Mar 31, 2025 | 1 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 11, 2026 |
| FY2025 | Sep 30, 2024 | 2 | Feb 11, 2026 |
| FY2025 | Jun 30, 2024 | 2 | Feb 11, 2026 |
| FY2025 | Mar 31, 2024 | 2 | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | 2 | Feb 12, 2025 |
| FY2024 | Sep 30, 2023 | 1 | Feb 12, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | 374.40M | Feb 8, 2018 |
| FY2017 | Dec 31, 2016 | 374.60M | Feb 8, 2018 |
| FY2017 | Dec 31, 2015 | 373.00M | Feb 8, 2018 |
| FY2017 | Dec 31, 2014 | 378.60M | Feb 8, 2018 |
| FY2014 | Dec 31, 2013 | 378 | Feb 12, 2015 |
| FY2013 | Dec 31, 2012 | 380 | Feb 13, 2014 |
| FY2012 | Dec 31, 2011 | 381 | Feb 27, 2013 |
| FY2011 | Dec 31, 2010 | 391 | Feb 13, 2012 |
| FY2010 | Dec 31, 2009 | 397.90M | Feb 18, 2011 |
| FY2009 | Dec 31, 2008 | 396.40M | Feb 26, 2010 |